The Blood of the Future Could be Made in a Lab

The coronavirus pandemic led to blood-donation shortages across the world, outlining the fragility of the pipeline. That has brought fresh urgency to research that has been decades in the making but is only now starting to become a reality: The production of artificial blood. Last year, researchers began a pioneering clinical trial, and more are on the way, bringing us closer to a world where blood factories augment supplies.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.